fda
Top drug regulator retiring
Lizzy scooped that Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring in July.
Corrigan-Curay, who took over as acting director of the FDA's drug center in January, broke the news to staff in an email. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their "unwavering support, especially during recent challenging times."
Read more from Lizzy here, and if you're having a difficult time keeping up with senior agency officials who've departed, Lizzy and J. Emory Parker created this handy tracker for you.
vaccines
The Balkanization of vaccine policy
The U.S. may be headed for a "choose your own adventure" approach to vaccine policy, Helen Branswell writes.
The CDC has been the authority on vaccine policy, but that might no longer be the case after HHS Secretary Roberty F. Kennedy Jr. fired all members of a key CDC expert advisory panel and replaced them with members who have less notable credentials. Some deeply distrust vaccines, and one embraces the moniker "anti-vaxxer."
Without the CDC as the North Star, specialists may consult their respective professional organizations, and parents who believe in vaccinating their children will consult one information source, while vaccine-skeptic parents will pick and choose vaccinations based on unfounded claims that support their predetermined beliefs. Read more.
vaccine advisers
Cassidy chimes in
Sen. Bill Cassidy (R-La.), a doctor, vaccine advocate and chair of the Senate health committee, is calling for a delay of this week's CDC advisory panel meeting, citing the new members' lack of experience and potential bias against some vaccines, Chelsea Cirruzzo reports.
"Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology. In particular, some lack experience studying new technologies such as mRNA vaccines, and may even have a preconceived bias against them," Cassidy wrote on the social media site X.
Cassidy cast the key vote to confirm Kennedy in February, but only after Cassidy said Kennedy had given him reassurances on vaccines.
congress
Medicaid expansion targeted
Many lobbyists, and some senators, were surprised when the Senate Finance Committee proposed more cuts to Medicaid funding than their House colleagues. Now some senators are pushing for even deeper cuts, and they're targeting Medicaid expansion, Daniel Payne reports.
Previously, Senate Republicans had further restricted states' ability to boost federal funding for increasing Medicaid payment rates to hospitals and other health care providers. Now, they're considering eliminating the higher federal match rate that states receive for people who became eligible for Medicaid after the Affordable Care Act expanded the program.
Hospitals were freaking out even before the new proposal popped up.
Sen. Josh Hawley (R-Mo.) said Monday evening that Senate Majority Leader John Thune (R-SD) told him the proposal is dead.
No comments